Zhejiang Huahai Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Zhejiang Huahai Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a cash flow conversion efficiency ratio of 0.029x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥282.81 Million ≈ $41.38 Million USD) by net assets (CN¥9.60 Billion ≈ $1.40 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Zhejiang Huahai Pharmaceutical Co Ltd worth for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Zhejiang Huahai Pharmaceutical Co Ltd (2001–2025)
Cash flow conversion efficiency of Zhejiang Huahai Pharmaceutical Co Ltd from 2001 to 2025. This chart illustrates how Zhejiang Huahai Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 600521 share price today for real-time trading data and today's change.
Zhejiang Huahai Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Zhejiang Huahai Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Zhejiang Huahai Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Huahai Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Review how much free cash does Zhejiang Huahai Pharmaceutical Co Ltd generate to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Geovis Technology Co Ltd
SHG:688568
|
0.020x |
|
Turk Telekomunikasyon AS
IS:TTKOM
|
0.158x |
|
Xiamen C&D Inc
SHG:600153
|
-0.060x |
|
Monday.Com Ltd
NASDAQ:MNDY
|
0.096x |
|
Companhia de Saneamento de Minas Gerais
SA:CSMG3
|
0.057x |
|
Puig Brands SA
NYSE:PUGBY
|
N/A |
|
Doximity Inc
NYSE:DOCS
|
0.115x |
|
Edgewise Therapeutics Inc
NASDAQ:EWTX
|
-0.086x |
Annual Cash Flow Conversion Efficiency for Zhejiang Huahai Pharmaceutical Co Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Huahai Pharmaceutical Co Ltd from 2001 to 2025. Also see Zhejiang Huahai Pharmaceutical Co Ltd balance sheet assets for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥9.46 Billion ≈ $1.38 Billion |
CN¥1.23 Billion ≈ $180.00 Million |
0.130x | -45.99% |
| 2024-12-31 | CN¥9.02 Billion ≈ $1.32 Billion |
CN¥2.17 Billion ≈ $317.93 Million |
0.241x | -10.35% |
| 2023-12-31 | CN¥8.25 Billion ≈ $1.21 Billion |
CN¥2.22 Billion ≈ $324.42 Million |
0.269x | +67.47% |
| 2022-12-31 | CN¥7.75 Billion ≈ $1.13 Billion |
CN¥1.24 Billion ≈ $181.85 Million |
0.160x | +15.85% |
| 2021-12-31 | CN¥6.78 Billion ≈ $991.59 Million |
CN¥938.43 Million ≈ $137.32 Million |
0.138x | -40.13% |
| 2020-12-31 | CN¥6.72 Billion ≈ $983.95 Million |
CN¥1.56 Billion ≈ $227.61 Million |
0.231x | -23.78% |
| 2019-12-31 | CN¥5.78 Billion ≈ $845.61 Million |
CN¥1.75 Billion ≈ $256.66 Million |
0.304x | +1780.57% |
| 2018-12-31 | CN¥4.21 Billion ≈ $615.58 Million |
CN¥67.90 Million ≈ $9.94 Million |
0.016x | -85.06% |
| 2017-12-31 | CN¥5.05 Billion ≈ $739.67 Million |
CN¥546.24 Million ≈ $79.93 Million |
0.108x | +14.22% |
| 2016-12-31 | CN¥4.58 Billion ≈ $669.88 Million |
CN¥433.10 Million ≈ $63.38 Million |
0.095x | +80.21% |
| 2015-12-31 | CN¥3.72 Billion ≈ $544.40 Million |
CN¥195.31 Million ≈ $28.58 Million |
0.052x | -47.82% |
| 2014-12-31 | CN¥3.27 Billion ≈ $477.93 Million |
CN¥328.61 Million ≈ $48.09 Million |
0.101x | -38.04% |
| 2013-12-31 | CN¥3.02 Billion ≈ $441.82 Million |
CN¥490.29 Million ≈ $71.75 Million |
0.162x | +29.80% |
| 2012-12-31 | CN¥1.95 Billion ≈ $285.21 Million |
CN¥243.83 Million ≈ $35.68 Million |
0.125x | -3.12% |
| 2011-12-31 | CN¥1.53 Billion ≈ $223.82 Million |
CN¥197.51 Million ≈ $28.90 Million |
0.129x | -43.15% |
| 2010-12-31 | CN¥1.32 Billion ≈ $192.92 Million |
CN¥299.47 Million ≈ $43.82 Million |
0.227x | -13.25% |
| 2009-12-31 | CN¥1.21 Billion ≈ $177.39 Million |
CN¥317.44 Million ≈ $46.45 Million |
0.262x | +243.02% |
| 2008-12-31 | CN¥1.10 Billion ≈ $161.41 Million |
CN¥84.20 Million ≈ $12.32 Million |
0.076x | -45.45% |
| 2007-12-31 | CN¥975.52 Million ≈ $142.75 Million |
CN¥136.52 Million ≈ $19.98 Million |
0.140x | +57.99% |
| 2006-12-31 | CN¥875.40 Million ≈ $128.10 Million |
CN¥77.54 Million ≈ $11.35 Million |
0.089x | +33.34% |
| 2005-12-31 | CN¥802.34 Million ≈ $117.41 Million |
CN¥53.30 Million ≈ $7.80 Million |
0.066x | -68.13% |
| 2004-12-31 | CN¥785.53 Million ≈ $114.95 Million |
CN¥163.73 Million ≈ $23.96 Million |
0.208x | +201.31% |
| 2003-12-31 | CN¥685.42 Million ≈ $100.30 Million |
CN¥47.41 Million ≈ $6.94 Million |
0.069x | -92.60% |
| 2002-12-31 | CN¥80.56 Million ≈ $11.79 Million |
CN¥75.34 Million ≈ $11.02 Million |
0.935x | +79.90% |
| 2001-12-31 | CN¥72.15 Million ≈ $10.56 Million |
CN¥37.51 Million ≈ $5.49 Million |
0.520x | -- |
About Zhejiang Huahai Pharmaceutical Co Ltd
Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production, and sales of generic drugs, biologics, drugs, and specialty active pharmaceutical ingredients in multiple dosage forms in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging componen… Read more